Saturna Capital’s BioNTech BNTX Stock Holding History

Saturna Capital’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,020	Closed	-$219K	–	176
2023 Q3	$219K	Sell	2,020 -5,514	-73%	-$610K	﹤0.01%	163
2023 Q2	$813K	Sell	7,534 -171	-2%	-$19.2K	0.01%	114
2023 Q1	$960K	Buy	7,705 +883	+13%	+$121K	0.02%	108
2022 Q4	$1.02M	Buy	6,822 +4,522	+197%	+$696K	0.02%	103
2022 Q3	$310K	Buy	+2,300	New	+$352K	0.01%	139
2022 Q1	–	Sell	-2,300	Closed	-$593K	–	171
2021 Q4	$593K	Hold	2,300	–	–	0.01%	122
2021 Q3	$628K	Hold	2,300	–	–	0.01%	118
2021 Q2	$515K	Hold	2,300	–	–	0.01%	132
2021 Q1	$251K	Buy	+2,300	New	+$244K	0.01%	153

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Saturna Capital's BNTX Position: Q4 2023 in Review

Saturna Capital sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 2,020 shares — an estimated $219K sold.

Saturna Capital first reported a position in BNTX in Q1 2021 and held it in 9 quarters. The position peaked at $1.02M in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

Saturna Capital reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
Saturna Capital sold 2,020 BioNTech shares in Q4 2023, an estimated $219K.
Saturna Capital first reported a position in BioNTech in Q1 2021 and held it in 9 quarters.
Saturna Capital's BioNTech position peaked at $1.02M in Q4 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Saturna Capital's 13F filing for Q4 2023, filed 6 Feb 2024.